Keros Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
96.67
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
4
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.23
|
-0.92
|
0.31
|
25.20%
|
|
2022-06-30
|
-1.06
|
-1.13
|
-0.07
|
-6.60%
|
|
2022-03-31
|
-0.86
|
-1.01
|
-0.15
|
-17.44%
|
|
2021-12-31
|
-0.92
|
-0.30
|
0.62
|
67.39%
|
|
2021-09-30
|
-0.72
|
-0.87
|
-0.15
|
-20.83%
|
|
2021-06-30
|
-0.65
|
-0.67
|
-0.02
|
-3.08%
|
|
2021-03-31
|
-0.58
|
-0.68
|
-0.10
|
-17.24%
|
|
2020-12-31
|
-0.57
|
-0.49
|
0.08
|
14.04%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-3.06
|
|
2021-12-31
|
-2.52
|
|
2020-12-31
|
-6.82
|